📊 Score Breakdown
Offering Ability
100
Cash Runway
95
Float Risk
15
Warrant Exposure
30
Convertible Debt—
🌦️ Dilution Forecast
🌩️
Severe
Multiple high-probability dilution events detected
78%
💰 Capital Raise
93%
• Critical: only 0.3 months cash remaining
• Active shelf registration ($100M, 5964% of market cap)
🔄 Reverse Split
70%
• 50-day avg $0.61 below $1 exchange minimum
• Only 0 months cash — financial pressure
📉 Score Deterioration
55%
• Score rose 57 points recently (worsening)
• Score already CRITICAL (77/100) — events likely imminent
💹 Market Data
Market Cap$1.68M
Shares Outstanding4.66M
Float4.55M
Cash$375.0K
Debt$913.0K
Short InterestN/A
🏛 Institutional Holdings
10 institutional holders · 60.4K shares
#1
UBS Group AG
47.2K shares
#2
Vanguard Group Inc
5.6K shares
#3
Geode Capital Management, LLC
2.1K shares
+ 7 more holders Sign up free to view →
📉 Short Interest
Short Interest665.1K
Days to Cover1.0
% of Float14.6%
FINRA data as of Apr 30, 2026
📁 Recent SEC Activity
xbrl
XBRL WARRANT
Mar 31, 2026
xbrl
XBRL CONVERTIBLE
Sep 30, 2025
424B3
ATM
May 04, 2026
S-1/A
SHELF
May 01, 2026
8-K
8K EVENT
Apr 29, 2026
Full SEC filing analysis available with free account →
📰 Recent News
No recent news
🔬 More Research for PFSA
📊 PFSA FDA Catalyst Timeline & Biotech Grade — BiotechSigns
📡 PFSA Signal Convergence & Dark Pool Activity — StonkWhisper
📄 PFSA Dilution Risk Analysis — Full In-Depth Report
Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.